240 related articles for article (PubMed ID: 19157923)
1. Chemical composition, radiopacity, and biocompatibility of Portland cement with bismuth oxide.
Hwang YC; Lee SH; Hwang IN; Kang IC; Kim MS; Kim SH; Son HH; Oh WM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Mar; 107(3):e96-102. PubMed ID: 19157923
[TBL] [Abstract][Full Text] [Related]
2. The chemical constitution and biocompatibility of accelerated Portland cement for endodontic use.
Camilleri J; Montesin FE; Di Silvio L; Pitt Ford TR
Int Endod J; 2005 Nov; 38(11):834-42. PubMed ID: 16218977
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the radiopacity and cytotoxicity of Portland cements containing bismuth oxide.
Kim EC; Lee BC; Chang HS; Lee W; Hong CU; Min KS
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jan; 105(1):e54-7. PubMed ID: 18155604
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the hydration and bioactivity of radiopacified tricalcium silicate cement, Biodentine and MTA Angelus.
Camilleri J; Sorrentino F; Damidot D
Dent Mater; 2013 May; 29(5):580-93. PubMed ID: 23537569
[TBL] [Abstract][Full Text] [Related]
5. Radiopacity and histological assessment of Portland cement plus bismuth oxide.
Coutinho-Filho T; De-Deus G; Klein L; Manera G; Peixoto C; Gurgel-Filho ED
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Dec; 106(6):e69-77. PubMed ID: 18926734
[TBL] [Abstract][Full Text] [Related]
6. Mineral trioxide aggregate and Portland cement promote biomineralization in vivo.
Dreger LA; Felippe WT; Reyes-Carmona JF; Felippe GS; Bortoluzzi EA; Felippe MC
J Endod; 2012 Mar; 38(3):324-9. PubMed ID: 22341069
[TBL] [Abstract][Full Text] [Related]
7. Study of the bismuth oxide concentration required to provide Portland cement with adequate radiopacity for endodontic use.
Bueno CE; Zeferino EG; Manhães LR; Rocha DG; Cunha RS; De Martin AS
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jan; 107(1):e65-9. PubMed ID: 19101486
[TBL] [Abstract][Full Text] [Related]
8. Chemical and physical surface and bulk material characterization of white ProRoot MTA and two Portland cements.
Dammaschke T; Gerth HU; Züchner H; Schäfer E
Dent Mater; 2005 Aug; 21(8):731-8. PubMed ID: 15935463
[TBL] [Abstract][Full Text] [Related]
9. In vitro cytotoxicity of white MTA, MTA Fillapex® and Portland cement on human periodontal ligament fibroblasts.
Yoshino P; Nishiyama CK; Modena KC; Santos CF; Sipert CR
Braz Dent J; 2013; 24(2):111-6. PubMed ID: 23780362
[TBL] [Abstract][Full Text] [Related]
10. Characterization of hydration products of mineral trioxide aggregate.
Camilleri J
Int Endod J; 2008 May; 41(5):408-17. PubMed ID: 18298574
[TBL] [Abstract][Full Text] [Related]
11. Ex vivo assessment of genotoxicity and cytotoxicity in murine fibroblasts exposed to white MTA or white Portland cement with 15% bismuth oxide.
Zeferino EG; Bueno CE; Oyama LM; Ribeiro DA
Int Endod J; 2010 Oct; 43(10):843-8. PubMed ID: 20722754
[TBL] [Abstract][Full Text] [Related]
12. Radiopacity and cytotoxicity of Portland cement containing zirconia doped bismuth oxide radiopacifiers.
Chen C; Hsieh SC; Teng NC; Kao CK; Lee SY; Lin CK; Yang JC
J Endod; 2014 Feb; 40(2):251-4. PubMed ID: 24461413
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the physical properties of an endodontic Portland cement incorporating alternative radiopacifiers used as root-end filling material.
Camilleri J
Int Endod J; 2010 Mar; 43(3):231-40. PubMed ID: 20158535
[TBL] [Abstract][Full Text] [Related]
14. Effect of ProRoot MTA, Portland cement, and amalgam on the expression of fibronectin, collagen I, and TGFβ by human periodontal ligament fibroblasts in vitro.
Fayazi S; Ostad SN; Razmi H
Indian J Dent Res; 2011; 22(2):190-4. PubMed ID: 21891883
[TBL] [Abstract][Full Text] [Related]
15. Replacement of radiopacifier in mineral trioxide aggregate; characterization and determination of physical properties.
Cutajar A; Mallia B; Abela S; Camilleri J
Dent Mater; 2011 Sep; 27(9):879-91. PubMed ID: 21571361
[TBL] [Abstract][Full Text] [Related]
16. Marginal adaptation and cytotoxicity of bone cement compared with amalgam and mineral trioxide aggregate as root-end filling materials.
Badr AE
J Endod; 2010 Jun; 36(6):1056-60. PubMed ID: 20478465
[TBL] [Abstract][Full Text] [Related]
17. Comparative chemical study of MTA and Portland cements.
Oliveira MG; Xavier CB; Demarco FF; Pinheiro AL; Costa AT; Pozza DH
Braz Dent J; 2007; 18(1):3-7. PubMed ID: 17639192
[TBL] [Abstract][Full Text] [Related]
18. Chemical constitution, physical properties, and biocompatibility of experimentally manufactured Portland cement.
Hwang YC; Kim DH; Hwang IN; Song SJ; Park YJ; Koh JT; Son HH; Oh WM
J Endod; 2011 Jan; 37(1):58-62. PubMed ID: 21146078
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the strength and radiopacity of Portland cement with varying additions of bismuth oxide.
Saliba E; Abbassi-Ghadi S; Vowles R; Camilleri J; Hooper S; Camilleri J
Int Endod J; 2009 Apr; 42(4):322-8. PubMed ID: 19220518
[TBL] [Abstract][Full Text] [Related]
20. Environmental scanning electron microscopy connected with energy dispersive x-ray analysis and Raman techniques to study ProRoot mineral trioxide aggregate and calcium silicate cements in wet conditions and in real time.
Gandolfi MG; Van Landuyt K; Taddei P; Modena E; Van Meerbeek B; Prati C
J Endod; 2010 May; 36(5):851-7. PubMed ID: 20416432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
